Gildas Tetaping Mbemya , Luis Alberto Vieira , Francisca Geovania Canafistula , Otília Deusdênia Loiola Pessoa , Ana Paula Ribeiro Rodrigues
{"title":"药用植物对改善雌性生殖功能的体内外贡献报道","authors":"Gildas Tetaping Mbemya , Luis Alberto Vieira , Francisca Geovania Canafistula , Otília Deusdênia Loiola Pessoa , Ana Paula Ribeiro Rodrigues","doi":"10.1016/j.recli.2016.11.002","DOIUrl":null,"url":null,"abstract":"<div><p>Medicinal plants are known as a prolific source of secondary metabolites which have important function both <em>in vivo</em> and <em>in vitro</em> during the ovarian folliculogenesis and steroidogenesis in many animal species. Some secondary metabolites can act as antioxidants generally through their ability to scavenge reactive oxygen species (ROS) or can regulate ovarian hormonal production. In general, these properties are responsible for the medicinal functions to treat woman infertility disorder. Some plants are constituted of biological actives substances which have been used to treat reproductive dysfunction. However, until recently, little was known about the implication of plants and/or their secondary metabolites on <em>in vitro</em> folliculogenesis and steroidogenesis. With the development of the technology, there is an increase implication of those substances in assisted reproductive technology (ART). The present review highlights some medicinal plants used in the treatment of woman disorders related to infertility. In addition, it provides an <em>in vivo</em> and <em>in vitro</em> overview of herbs and their active compounds with claims for improvement of ovarian activity thus showing their implication in female reproductive health care.</p></div>","PeriodicalId":101073,"journal":{"name":"Reprodu??o & Climatério","volume":"32 2","pages":"Pages 109-119"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.recli.2016.11.002","citationCount":"27","resultStr":"{\"title\":\"Reports on in vivo and in vitro contribution of medicinal plants to improve the female reproductive function\",\"authors\":\"Gildas Tetaping Mbemya , Luis Alberto Vieira , Francisca Geovania Canafistula , Otília Deusdênia Loiola Pessoa , Ana Paula Ribeiro Rodrigues\",\"doi\":\"10.1016/j.recli.2016.11.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Medicinal plants are known as a prolific source of secondary metabolites which have important function both <em>in vivo</em> and <em>in vitro</em> during the ovarian folliculogenesis and steroidogenesis in many animal species. Some secondary metabolites can act as antioxidants generally through their ability to scavenge reactive oxygen species (ROS) or can regulate ovarian hormonal production. In general, these properties are responsible for the medicinal functions to treat woman infertility disorder. Some plants are constituted of biological actives substances which have been used to treat reproductive dysfunction. However, until recently, little was known about the implication of plants and/or their secondary metabolites on <em>in vitro</em> folliculogenesis and steroidogenesis. With the development of the technology, there is an increase implication of those substances in assisted reproductive technology (ART). The present review highlights some medicinal plants used in the treatment of woman disorders related to infertility. In addition, it provides an <em>in vivo</em> and <em>in vitro</em> overview of herbs and their active compounds with claims for improvement of ovarian activity thus showing their implication in female reproductive health care.</p></div>\",\"PeriodicalId\":101073,\"journal\":{\"name\":\"Reprodu??o & Climatério\",\"volume\":\"32 2\",\"pages\":\"Pages 109-119\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.recli.2016.11.002\",\"citationCount\":\"27\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reprodu??o & Climatério\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1413208716300735\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reprodu??o & Climatério","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1413208716300735","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Reports on in vivo and in vitro contribution of medicinal plants to improve the female reproductive function
Medicinal plants are known as a prolific source of secondary metabolites which have important function both in vivo and in vitro during the ovarian folliculogenesis and steroidogenesis in many animal species. Some secondary metabolites can act as antioxidants generally through their ability to scavenge reactive oxygen species (ROS) or can regulate ovarian hormonal production. In general, these properties are responsible for the medicinal functions to treat woman infertility disorder. Some plants are constituted of biological actives substances which have been used to treat reproductive dysfunction. However, until recently, little was known about the implication of plants and/or their secondary metabolites on in vitro folliculogenesis and steroidogenesis. With the development of the technology, there is an increase implication of those substances in assisted reproductive technology (ART). The present review highlights some medicinal plants used in the treatment of woman disorders related to infertility. In addition, it provides an in vivo and in vitro overview of herbs and their active compounds with claims for improvement of ovarian activity thus showing their implication in female reproductive health care.